Key Takeaways:
- Clarins launches longevity research center to advance science-backed skincare innovation.
- Longevity replaces anti-aging as beauty’s next major growth strategy.
- Beauty shifts toward preventive wellness, epigenetics, and cellular skin health.
The beauty industry’s obsession with anti-aging is being replaced by something bigger: longevity. As consumers increasingly view skin as a reflection of overall health rather than a purely aesthetic concern, brands are racing to establish credibility through wellness, one of beauty’s fastest-growing areas
The global wellness economy reached $6.8 trillion in 2024 and is projected to grow to $9.8 trillion by 2029, reflecting rising demand for preventive health, well-being, and longevity-focused solutions. Against this backdrop, Clarins has launched the Dr. Olivier Courtin Clarins Longevity Research Center, a dedicated scientific hub designed to deepen understanding of the biological mechanisms behind skin aging and translate those findings into future skincare innovations.
The move formalizes more than three decades of investment in longevity research. According to the company, its work in the field has generated 10 patents, 13 peer-reviewed scientific publications, and 12 collaborations with leading international research institutions
“Today the science of longevity allows us to greatly influence the behavior of skin, and I imagine it will undoubtedly reverse it sometime in the future,” said Dr. Olivier Courtin Clarins, Chairman of the new research center, in a company press release. “The strength of this science is that we can cultivate both beauty and skin health in a truly proactive way.”
Moving Beyond Anti-Aging
The launch reflects a wider shift across the beauty sector, where aging is increasingly being framed as a biological process that can be influenced rather than an inevitable decline that must simply be concealed
Central to Clarins’ approach is epigenetics, the study of how environmental and lifestyle factors influence gene expression. The company cites research indicating that approximately 15% of gene expression is determined by inheritance, while up to 85% may be influenced by external factors such as nutrition, sleep, stress, physical activity, and environmental exposure
“Our lifestyle has a direct impact on gene expression, chronic inflammation, oxidative stress, mitochondrial function and cellular repair,” said Courtin Clarins in the press release. “The skin is an excellent reflection of these dynamics.”
The growing interest in epigenetics mirrors broader consumer behavior. According to multiple wellness and beauty trend reports, consumers are increasingly seeking products and services that promise long-term health benefits, preventative care, and measurable biological outcomes rather than quick cosmetic fixes
Building Scientific Infrastructure
Operating from Clarins’ Paris headquarters and research laboratories in Pontoise, the new center will be overseen by an international scientific committee and bring together specialists across aging biology, dermatology, epidemiology, behavioral science, biomedical engineering, and data science
Its mandate extends beyond product development. The center will guide future research priorities, establish doctoral and postdoctoral research programs with universities and institutes worldwide, and support scientific publications, workshops, and industry symposia
The investment highlights a growing trend among beauty companies seeking to strengthen scientific credentials as competition intensifies around longevity claims. As brands increasingly borrow language from biotechnology, healthcare, and wellness, research-backed validation is becoming a key differentiator
Translating Science into Commercial Innovation
For Clarins, the center serves as both a research platform and a product innovation engine
The company has identified eight biological hallmarks linked to skin longevity, including epigenetic changes, chronic inflammation, mitochondrial dysfunction, cellular senescence, and impaired autophagy. Existing products across its portfolio are already positioned as targeting these pathways through ingredients and technologies designed to support long-term skin function and resilience
This approach reflects a broader evolution within prestige beauty where brands are shifting away from traditional age-based marketing toward claims centered on cellular health, skin performance, and biological optimization
“Longevity has surpassed the mere definition of beauty,” said Courtin Clarins in a press release. “At Clarins, we focus less on treating the outward signs of aging but rather center our research on delaying or even reversing age-related behaviors in the skin.”
As beauty, wellness, and healthcare continue to converge, longevity is emerging as one of the industry’s most significant growth opportunities
For brands, the appeal extends beyond product innovation. Longevity creates opportunities for deeper consumer engagement through education, diagnostics, personalized skincare, and wellness ecosystems that span multiple categories
Clarins’ new research center signals that the company sees longevity not as a trend but as a long-term strategic pillar. In an industry increasingly defined by science-backed claims and preventive health narratives, the question is no longer whether longevity belongs in beauty, but which companies will first establish authority in the category
